Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration:Rebecca Zisser/Axios
PatientsLikeMe, a health-tech startup that connects patients with similar medical conditions, is being forced to find a buyer after the Committee on Foreign Investment in the U.S. (CFIUS) ordered Chinese firm iCarbonX, its majority owner, to divest its stake in the company.
The big picture: This is the latest sign of the Trump administration's growing concern over Chinese ownership of U.S. firms that collect consumer data. CFIUS ordered Beijing Kunlun Tech to give up its control of Grindr last week, arguing the Chinese firm's ownership of the app — which came under fire last year for sharing customers' HIV status — constituted a threat to U.S. national security.
Our thought bubble, per Axios' Ina Fried: The questions now are where the U.S. will draw the line when it comes to Chinese acquisitions and how far back it will go to unwind deals.